Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-164.8M
Cash
635.2M
Avg Qtr Burn
-54.08M
Short % of Float
11.19%
Insider Ownership
8.14%
Institutional Own.
-
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Izokibep Details Hidradenitis suppurativa | Phase 3 Update | |
Izokibep Details Axial spondyloarthritis | Phase 3 Initiation | |
Izokibep Details Psoriatic arthritis | Phase 2/3 Data readout | |
Izokibep Details Uveitis , Eye disease | Phase 2/3 Data readout | |
Lonigutamab Details Thyroid Eye Disease , Eye disease | Phase 2 Data readout | |
SLRN-517 Details Allergy, KIT/Mast cell diseases, Inflammatory disease | Phase 1/2 Data readout |